Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Mt69sinaion Nov 07, 2019 12:24pm
546 Views
Post# 30322054

Aphria Inc (NYSE:APHA) Expected to Announce Quarterly Sales

Aphria Inc (NYSE:APHA) Expected to Announce Quarterly Sales

Aphria Inc (NYSE:APHA) Expected to Announce Quarterly Sales of $100.92 Million 

Posted by Steve Fairfield on Nov 6th, 2019 

https://slatersentinel.com/news/2019/11/06/aphria-inc-nyseapha-expected-to-announce-quarterly-sales-of-100-92-million.html 

Equities analysts expect that Aphria Inc (NYSE:APHA) will post sales of $100.92 million for the current quarter, according to Zacks. Three analysts have issued estimates for Aphria’s earnings. The highest sales estimate is $104.70 million and the lowest is $95.84 million. Aphria posted sales of $16.58 million in the same quarter last year, which would indicate a positive year over year growth rate of 508.7%. The firm is expected to report its next earnings report on Friday, January 10th. 

According to Zacks, analysts expect that Aphria will report full year sales of $463.69 million for the current year, with estimates ranging from $410.27 million to $514.18 million. For the next fiscal year, analysts anticipate that the firm will post sales of $636.30 million, with estimates ranging from $451.19 million to $766.81 million. Zacks’ sales averages are an average based on a survey of analysts that cover Aphria. 

Aphria (NYSE:APHA) last issued its quarterly earnings results on Tuesday, October 15th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.10. The firm had revenue of $126.10 million for the quarter, compared to analysts’ expectations of $131.15 million. The firm’s revenue was up 848.1% on a year-over-year basis. 

A number of research analysts have recently commented on APHA shares. CIBC reaffirmed a “sell” rating and set a $6.50 price target on shares of Aphria in a research report on Wednesday, October 16th. Pi Financial set a $9.00 price target on Aphria and gave the company a “buy” rating in a research report on Tuesday, October 15th. Jefferies Financial Group set a $8.30 price target on Aphria and gave the company a “buy” rating in a research report on Tuesday, October 15th. Zacks Investment Research raised Aphria from a “hold” rating to a “buy” rating and set a $5.50 price target on the stock in a research report on Thursday, October 17th. Finally, Cantor Fitzgerald started coverage on Aphria in a research report on Tuesday. They set an “overweight” rating on the stock. One analyst has rated the stock with a sell rating, one has issued a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $11.51. 
Large investors have recently added to or reduced their stakes in the stock. Synovus Financial Corp raised its stake in shares of Aphria by 56.9% during the 2nd quarter. Synovus Financial Corp now owns 5,514 shares of the company’s stock valued at $39,000 after purchasing an additional 2,000 shares during the period. Capital Investment Advisory Services LLC raised its stake in shares of Aphria by 2,233.3% during the 2nd quarter. Capital Investment Advisory Services LLC now owns 7,000 shares of the company’s stock valued at $43,000 after purchasing an additional 6,700 shares during the period. Liberty Wealth Management LLC bought a new stake in shares of Aphria during the 2nd quarter valued at $44,000. Tower Research Capital LLC TRC raised its stake in shares of Aphria by 76.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,248 shares of the company’s stock valued at $44,000 after purchasing an additional 2,698 shares during the period. Finally, Lindbrook Capital LLC bought a new stake in shares of Aphria during the 2nd quarter valued at $53,000. Institutional investors own 10.94% of the company’s stock. 

Shares of NYSE APHA opened at $5.14 on Wednesday. Aphria has a one year low of $3.75 and a one year high of $13.45. The business’s fifty day moving average price is $5.30 and its 200-day moving average price is $6.39. The stock has a market capitalization of $1.31 billion, a PE ratio of -46.73 and a beta of 2.83. 


$$$$$APHA$$$$$

$inai

 

Bullboard Posts